Skip to content

Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy

A Prospective, Randomized, Single-Blind, Standard Care Controlled, Multi-Center, Phase II Study Evaluating the Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00598130
Acronym
Fleece
Enrollment
30
Registered
2008-01-18
Start date
2008-02-29
Completion date
2009-02-28
Last updated
2009-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemostatic Techniques, Nephrectomy

Keywords

Patients undergoing elective open partial nephrectomy surgery, Excision of a kidney

Brief summary

This is a prospective, randomized, single blind, standard care- controlled study, which will include a total of 30 patients divided into two treatment arms: First are: patents who will be treated in accordance with standard of care. Second arm: patients for which the Fibrin Fleece will be applied directly on the active bleeding site.

Interventions

BIOLOGICALFleece

Fibrin Patch

Sponsors

OMRIX Biopharmaceuticals
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective open partial nephrectomy * Patients must be willing to participate in the study, and provide written informed consent

Exclusion criteria

* Patients with a tumor diameter greater than 4 cm * Any additional surgical intervention other than partial nephrectomy * Patients with only one functional kidney * Patients with known intolerance to blood products or other components of the product

Design outcomes

Primary

MeasureTime frame
Proportion of successes at 10 minutes following randomization10 minutes

Secondary

MeasureTime frame
Proportion of successes at 5 minutes following randomization5 minutes

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026